What is the catalog number for C1QBP Rabbit Monoclonal Antibody?

The catalog number for C1QBP Rabbit Monoclonal Antibody is orb866788.

What sizes are available for C1QBP Rabbit Monoclonal Antibody?

C1QBP Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is C1QBP Rabbit Monoclonal Antibody in stock?

C1QBP Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

C1QBP Rabbit Monoclonal Antibody

Anti-C1QBP Rabbit Monoclonal Antibody. Tested in WB, IHC applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Tumor necrosis factor receptor superfamily member 1B; Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; TNF-RII; TNFR-II; p75; p80 TNF-alpha receptor; CD120b; Etanercept; Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2; TBP-2; TBPII; TNFRSF1B; TNFBR, TNFR2

UniProt

Q07021

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human C1QBP

Target

Complement component 1 Q subcomponent-binding protein, mitochondrial

Clonality

Monoclonal

Clone

B49E66

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-1:2000 IHC 1:50-1:200

Form

Liquid

Molecular Weight

33 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.